CD28: A Potential Drug Target for Cancer and Other Diseases (G55297)
CD28: A Potential Drug Target for Cancer and Other Diseases
CCDC91 (DKFZp779L1558), also known as CD28, is a protein that is expressed in various tissues throughout the body, including the immune system, and is involved in cell adhesion, migration, and survival. It has also been shown to play a role in the development and progression of various diseases, including cancer.
Recent studies have identified CCDC91 as a potential drug target for the treatment of various diseases, including cancer. One of the main reasons for its potential as a drug target is its involvement in the development of cancer stem cells, which are a highly aggressive form of cells that can evade the immune system and continue to divide and proliferate even in the presence of treatments.
In addition to its role in cancer development, CCDC91 has also been shown to contribute to the development of other diseases, including autoimmune disorders and neurodegenerative diseases. This makes it an attractive target for researchers to investigate with the goal of developing new treatments for these conditions.
One of the key challenges in studying CCDC91 as a drug target is its complex structure and the various ways in which it can interact with other proteins. Despite its potential as a drug target, much work remains to be done in order to fully understand its role in these diseases and to develop effective treatments.
In conclusion, CCDC91 is a protein that has the potential to be a drug target for the treatment of various diseases, including cancer. Its complex structure and involvement in the development of cancer stem cells make it an attractive target for researchers to investigate, and further studies are needed to fully understand its role in these diseases and to develop effective treatments.
Protein Name: Coiled-coil Domain Containing 91
Functions: Involved in the regulation of membrane traffic through the trans-Golgi network (TGN). Functions in close cooperation with the GGAs in the sorting of hydrolases to lysosomes
More Common Targets
CCDC92 | CCDC92B | CCDC93 | CCDC96 | CCDC97 | CCDC9B | CCDST | CCEPR | CCER1 | CCER2 | CCHCR1 | CCIN | CCK | CCK receptor | CCKAR | CCKBR | CCL1 | CCL11 | CCL13 | CCL14 | CCL15 | CCL15-CCL14 | CCL16 | CCL17 | CCL18 | CCL19 | CCL2 | CCL20 | CCL21 | CCL22 | CCL23 | CCL24 | CCL25 | CCL26 | CCL27 | CCL28 | CCL3 | CCL3-AS1 | CCL3L1 | CCL3L3 | CCL3P1 | CCL4 | CCL4L1 | CCL4L2 | CCL5 | CCL7 | CCL8 | CCM2 | CCM2L | CCN1 | CCN2 | CCN3 | CCN4 | CCN5 | CCN6 | CCNA1 | CCNA2 | CCNB1 | CCNB1IP1 | CCNB2 | CCNB2P1 | CCNB3 | CCNC | CCND1 | CCND2 | CCND2-AS1 | CCND3 | CCNDBP1 | CCNE1 | CCNE2 | CCNF | CCNG1 | CCNG2 | CCNH | CCNI | CCNI2 | CCNJ | CCNJL | CCNK | CCNL1 | CCNL2 | CCNO | CCNP | CCNQ | CCNQP1 | CCNT1 | CCNT2 | CCNT2-AS1 | CCNT2P1 | CCNY | CCNYL1 | CCNYL2 | CCP110 | CCPG1 | CCR1 | CCR10 | CCR12P | CCR2 | CCR3 | CCR4